Nervonik
Designed For Motion
- Headquarters
- Los Angeles, California
- Employees
- 1–10
- Business Model
- B2B
- Website
- nervonik.com
- Last Round
- SAFEMar 2025
- Rounds
- 2
About
Nervonik is developing next-generation peripheral nerve stimulation (PNS) technology featuring a novel, patented trifecta system that eliminates technical barriers to biosensing in high-motion applications. The company's miniaturized devices address limitations of existing PNS devices by improving lead placement, programming flexibility, energy efficiency, and long-term efficacy. Nervonik's technology is currently under development and has not yet received FDA clearance or approval.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Mar 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Create Free AccountInvestors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...
Healthcare company in Europe
Mehiläinen is a leading Finnish private healthcare company providing medical, health, and special...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Biopharmaceutical services company